Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-09-01

AUTHORS

O Legrand, G Simonin, R Zittoun, J-P Marie

ABSTRACT

The role of LRP in clinical drug resistance in acute myeloid leukemia (AML) is controversial. We therefore compared multiple assays, including RT-PCR, immunocytochemistry (ICC) and flow cytometry (FC), in 10 cell lines and in 47 fresh and thawed AML cells in order to validate and to quantitate measures for LRP phenotype detection. We also compared different ways of expressing the results. Lastly, in cell lines, we analyzed the 50% lethal concentration (LC50), by MTT assay, of cisplatin which could estimate the functionality of LRP. The reproducibility of LRP detection measured by RT-PCR, ICC and FC was good. In the same way, within the same technique, there was good correlation between the different methods of expressing the results of LRP level. Therefore, the discrepancies noted with the three techniques used were neither a problem of reproducibility nor a problem of results expression. On the other hand, there was only a correlation between ICC and FC, and no correlation between RT-PCR and LRP protein detection techniques. Therefore, RT-PCR is probably not the optimal technique for LRP detection. We have shown in 10 cell lines a higher correlation between FC and LC50 of cisplatin than between ICC and LC50 of cisplatin and no correlation between RT-PCR and LC50 of cisplatin. For five patients, there was a dissociation between ICC and FC. Four patients were positive by FC and negative by ICC and only one patient was negative by FC and positive by ICC. Therefore, if in vitro resistance to cisplatin represents the functionality of LRP, we recommend the use of FC rather than ICC to detect LRP expression. Besides the measurement of LRP as a diagnostic tool in the evaluation of resistance to chemotherapy in patients with AML, we urgently need to establish a functional test in order to assess LRP activity. More... »

PAGES

1367-1374

References to SciGraph publications

  • 1991. Quantitative Estimation of MDR1 mRNA Levels by Polymerase Chain Reaction in MOLECULAR AND CELLULAR BIOLOGY OF MULTIDRUG RESISTANCE IN TUMOR CELLS
  • 1995-06-01. The drug resistance-related protein LRP is the human major vault protein in NATURE MEDICINE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/sj.leu.2401117

    DOI

    http://dx.doi.org/10.1038/sj.leu.2401117

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1027398728

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/9737684


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Acute Disease", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cisplatin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Flow Cytometry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immunohistochemistry", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Leukemia, Myeloid", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Proteins", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phenotype", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Polymerase Chain Reaction", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "RNA, Messenger", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reproducibility of Results", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tumor Cells, Cultured", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vault Ribonucleoprotein Particles", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.462844.8", 
              "name": [
                "Service d'matologie Biologique, Paris, France", 
                "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Legrand", 
            "givenName": "O", 
            "id": "sg:person.0752753564.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752753564.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.462844.8", 
              "name": [
                "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Simonin", 
            "givenName": "G", 
            "id": "sg:person.0603732723.41", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603732723.41"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Service d'matologie Clinique, Paris, France", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France", 
                "Service d'matologie Clinique, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zittoun", 
            "givenName": "R", 
            "id": "sg:person.0717353373.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717353373.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France", 
              "id": "http://www.grid.ac/institutes/grid.462844.8", 
              "name": [
                "Service d'matologie Biologique, Paris, France", 
                "EA1529, Universit\u00e9 Paris 6, Formation de Recherche Associ\u00e9e Claude Bernard sur le Traitement des H\u00e9mopathies Malignes, Paris, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Marie", 
            "givenName": "J-P", 
            "id": "sg:person.01064502270.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064502270.46"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/978-1-4615-3794-6_17", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027880744", 
              "https://doi.org/10.1007/978-1-4615-3794-6_17"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm0695-578", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031275541", 
              "https://doi.org/10.1038/nm0695-578"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "1998-09-01", 
        "datePublishedReg": "1998-09-01", 
        "description": "The role of LRP in clinical drug resistance in acute myeloid leukemia (AML) is controversial. We therefore compared multiple assays, including RT-PCR, immunocytochemistry (ICC) and flow cytometry (FC), in 10 cell lines and in 47 fresh and thawed AML cells in order to validate and to quantitate measures for LRP phenotype detection. We also compared different ways of expressing the results. Lastly, in cell lines, we analyzed the 50% lethal concentration (LC50), by MTT assay, of cisplatin which could estimate the functionality of LRP. The reproducibility of LRP detection measured by RT-PCR, ICC and FC was good. In the same way, within the same technique, there was good correlation between the different methods of expressing the results of LRP level. Therefore, the discrepancies noted with the three techniques used were neither a problem of reproducibility nor a problem of results expression. On the other hand, there was only a correlation between ICC and FC, and no correlation between RT-PCR and LRP protein detection techniques. Therefore, RT-PCR is probably not the optimal technique for LRP detection. We have shown in 10 cell lines a higher correlation between FC and LC50 of cisplatin than between ICC and LC50 of cisplatin and no correlation between RT-PCR and LC50 of cisplatin. For five patients, there was a dissociation between ICC and FC. Four patients were positive by FC and negative by ICC and only one patient was negative by FC and positive by ICC. Therefore, if in vitro resistance to cisplatin represents the functionality of LRP, we recommend the use of FC rather than ICC to detect LRP expression. Besides the measurement of LRP as a diagnostic tool in the evaluation of resistance to chemotherapy in patients with AML, we urgently need to establish a functional test in order to assess LRP activity.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/sj.leu.2401117", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1097065", 
            "issn": [
              "0887-6924", 
              "1476-5551"
            ], 
            "name": "Leukemia", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "9", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "12"
          }
        ], 
        "keywords": [
          "acute myeloid leukemia", 
          "RT-PCR", 
          "myeloid leukemia", 
          "adult acute myeloid leukemia", 
          "cell lines", 
          "clinical drug resistance", 
          "LRP expression", 
          "AML cells", 
          "patients", 
          "LRP levels", 
          "drug resistance", 
          "cisplatin", 
          "immunocytochemistry", 
          "role of LRP", 
          "MTT assay", 
          "functional tests", 
          "diagnostic tool", 
          "leukemia", 
          "protein gene expression", 
          "LRP activity", 
          "optimal technique", 
          "Results Expression", 
          "use of FC", 
          "phenotype detection", 
          "multiple assays", 
          "expression", 
          "gene expression", 
          "LRP", 
          "assays", 
          "chemotherapy", 
          "FC", 
          "protein detection techniques", 
          "lethal concentration", 
          "cytometry", 
          "correlation", 
          "evaluation", 
          "resistance", 
          "good correlation", 
          "high correlation", 
          "LC50", 
          "cells", 
          "critical evaluation", 
          "same technique", 
          "lines", 
          "detection", 
          "evaluation of resistance", 
          "levels", 
          "reproducibility", 
          "activity", 
          "problems of reproducibility", 
          "role", 
          "measures", 
          "test", 
          "results", 
          "concentration", 
          "use", 
          "same way", 
          "technique", 
          "different methods", 
          "hand", 
          "discrepancy", 
          "tool", 
          "dissociation", 
          "method", 
          "measurements", 
          "different ways", 
          "order", 
          "problem", 
          "way", 
          "functionality", 
          "detection techniques"
        ], 
        "name": "Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques", 
        "pagination": "1367-1374", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1027398728"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/sj.leu.2401117"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "9737684"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/sj.leu.2401117", 
          "https://app.dimensions.ai/details/publication/pub.1027398728"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-06-01T22:00", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220601/entities/gbq_results/article/article_288.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/sj.leu.2401117"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401117'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401117'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401117'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.leu.2401117'


     

    This table displays all metadata directly associated to this object as RDF triples.

    227 TRIPLES      22 PREDICATES      114 URIs      104 LITERALS      22 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/sj.leu.2401117 schema:about N2cfb3a2a25a14b9e88d20107f3b20f54
    2 N407636e6d6154202aaddedfaa12290bd
    3 N5e0da1f8b0554cbdaa88ee9abb86ca65
    4 N6e2601ae01494d8fa644e83af2b97504
    5 N86297f6632c14c8299c702d0581c1d8d
    6 N8c5c3fea0ca84bd39697f682d63272fb
    7 Naf0ef5869b6148a49637c866b46913b8
    8 Nc26c3182015c4f3aacb8bfa9b42b2740
    9 Nc6822a64b82e4f5d90ad1fee650dbdb6
    10 Nc8ead19db17c4591835c850a4c6b842b
    11 Ncf283e527c304a618952c078262a0727
    12 Ne4d6e961853a41ca8aa23a77dd5aef79
    13 Nec72ad457026468caab6874b4b12f704
    14 Nedfde5b78b734cbba443acc68f152d70
    15 Nf275fd34cbd5452cb087a66a03cbfd1b
    16 anzsrc-for:11
    17 anzsrc-for:1102
    18 schema:author N9860f97ae53e45c6a48d6cf9a4aef647
    19 schema:citation sg:pub.10.1007/978-1-4615-3794-6_17
    20 sg:pub.10.1038/nm0695-578
    21 schema:datePublished 1998-09-01
    22 schema:datePublishedReg 1998-09-01
    23 schema:description The role of LRP in clinical drug resistance in acute myeloid leukemia (AML) is controversial. We therefore compared multiple assays, including RT-PCR, immunocytochemistry (ICC) and flow cytometry (FC), in 10 cell lines and in 47 fresh and thawed AML cells in order to validate and to quantitate measures for LRP phenotype detection. We also compared different ways of expressing the results. Lastly, in cell lines, we analyzed the 50% lethal concentration (LC50), by MTT assay, of cisplatin which could estimate the functionality of LRP. The reproducibility of LRP detection measured by RT-PCR, ICC and FC was good. In the same way, within the same technique, there was good correlation between the different methods of expressing the results of LRP level. Therefore, the discrepancies noted with the three techniques used were neither a problem of reproducibility nor a problem of results expression. On the other hand, there was only a correlation between ICC and FC, and no correlation between RT-PCR and LRP protein detection techniques. Therefore, RT-PCR is probably not the optimal technique for LRP detection. We have shown in 10 cell lines a higher correlation between FC and LC50 of cisplatin than between ICC and LC50 of cisplatin and no correlation between RT-PCR and LC50 of cisplatin. For five patients, there was a dissociation between ICC and FC. Four patients were positive by FC and negative by ICC and only one patient was negative by FC and positive by ICC. Therefore, if in vitro resistance to cisplatin represents the functionality of LRP, we recommend the use of FC rather than ICC to detect LRP expression. Besides the measurement of LRP as a diagnostic tool in the evaluation of resistance to chemotherapy in patients with AML, we urgently need to establish a functional test in order to assess LRP activity.
    24 schema:genre article
    25 schema:inLanguage en
    26 schema:isAccessibleForFree false
    27 schema:isPartOf N2a77b3b434d24d41a921a36947df90ac
    28 Nadcc3c8c808d44a28789a3e05633eeba
    29 sg:journal.1097065
    30 schema:keywords AML cells
    31 FC
    32 LC50
    33 LRP
    34 LRP activity
    35 LRP expression
    36 LRP levels
    37 MTT assay
    38 RT-PCR
    39 Results Expression
    40 activity
    41 acute myeloid leukemia
    42 adult acute myeloid leukemia
    43 assays
    44 cell lines
    45 cells
    46 chemotherapy
    47 cisplatin
    48 clinical drug resistance
    49 concentration
    50 correlation
    51 critical evaluation
    52 cytometry
    53 detection
    54 detection techniques
    55 diagnostic tool
    56 different methods
    57 different ways
    58 discrepancy
    59 dissociation
    60 drug resistance
    61 evaluation
    62 evaluation of resistance
    63 expression
    64 functional tests
    65 functionality
    66 gene expression
    67 good correlation
    68 hand
    69 high correlation
    70 immunocytochemistry
    71 lethal concentration
    72 leukemia
    73 levels
    74 lines
    75 measurements
    76 measures
    77 method
    78 multiple assays
    79 myeloid leukemia
    80 optimal technique
    81 order
    82 patients
    83 phenotype detection
    84 problem
    85 problems of reproducibility
    86 protein detection techniques
    87 protein gene expression
    88 reproducibility
    89 resistance
    90 results
    91 role
    92 role of LRP
    93 same technique
    94 same way
    95 technique
    96 test
    97 tool
    98 use
    99 use of FC
    100 way
    101 schema:name Lung resistance protein (LRP) gene expression in adult acute myeloid leukemia: a critical evaluation by three techniques
    102 schema:pagination 1367-1374
    103 schema:productId N0cd1c92df06847308e39999bfbd93d38
    104 N29feeb5daef247988ddfc30c2f73d4e8
    105 Ncfd7c5ccd95746e6ad56b11582794b14
    106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027398728
    107 https://doi.org/10.1038/sj.leu.2401117
    108 schema:sdDatePublished 2022-06-01T22:00
    109 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    110 schema:sdPublisher N8e84e93f46124cc19e75562fa96ec91e
    111 schema:url https://doi.org/10.1038/sj.leu.2401117
    112 sgo:license sg:explorer/license/
    113 sgo:sdDataset articles
    114 rdf:type schema:ScholarlyArticle
    115 N0cd1c92df06847308e39999bfbd93d38 schema:name doi
    116 schema:value 10.1038/sj.leu.2401117
    117 rdf:type schema:PropertyValue
    118 N29feeb5daef247988ddfc30c2f73d4e8 schema:name dimensions_id
    119 schema:value pub.1027398728
    120 rdf:type schema:PropertyValue
    121 N2a77b3b434d24d41a921a36947df90ac schema:issueNumber 9
    122 rdf:type schema:PublicationIssue
    123 N2cfb3a2a25a14b9e88d20107f3b20f54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Tumor Cells, Cultured
    125 rdf:type schema:DefinedTerm
    126 N407636e6d6154202aaddedfaa12290bd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    127 schema:name Vault Ribonucleoprotein Particles
    128 rdf:type schema:DefinedTerm
    129 N44cfce8d74b34b8597cc047d2a652b88 rdf:first sg:person.0717353373.00
    130 rdf:rest Nec1af68c6c2543668831474c8e9bf62b
    131 N5e0da1f8b0554cbdaa88ee9abb86ca65 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Adult
    133 rdf:type schema:DefinedTerm
    134 N6e2601ae01494d8fa644e83af2b97504 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Polymerase Chain Reaction
    136 rdf:type schema:DefinedTerm
    137 N86297f6632c14c8299c702d0581c1d8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Immunohistochemistry
    139 rdf:type schema:DefinedTerm
    140 N8c5c3fea0ca84bd39697f682d63272fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Flow Cytometry
    142 rdf:type schema:DefinedTerm
    143 N8e84e93f46124cc19e75562fa96ec91e schema:name Springer Nature - SN SciGraph project
    144 rdf:type schema:Organization
    145 N9860f97ae53e45c6a48d6cf9a4aef647 rdf:first sg:person.0752753564.08
    146 rdf:rest Nf45d263c37ab41f6b61b6309b0facac4
    147 Nadcc3c8c808d44a28789a3e05633eeba schema:volumeNumber 12
    148 rdf:type schema:PublicationVolume
    149 Naf0ef5869b6148a49637c866b46913b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Neoplasm Proteins
    151 rdf:type schema:DefinedTerm
    152 Nc26c3182015c4f3aacb8bfa9b42b2740 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Cisplatin
    154 rdf:type schema:DefinedTerm
    155 Nc6822a64b82e4f5d90ad1fee650dbdb6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Phenotype
    157 rdf:type schema:DefinedTerm
    158 Nc8ead19db17c4591835c850a4c6b842b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    159 schema:name RNA, Messenger
    160 rdf:type schema:DefinedTerm
    161 Ncf283e527c304a618952c078262a0727 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    162 schema:name Reproducibility of Results
    163 rdf:type schema:DefinedTerm
    164 Ncfd7c5ccd95746e6ad56b11582794b14 schema:name pubmed_id
    165 schema:value 9737684
    166 rdf:type schema:PropertyValue
    167 Ne4d6e961853a41ca8aa23a77dd5aef79 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    168 schema:name Leukemia, Myeloid
    169 rdf:type schema:DefinedTerm
    170 Nec1af68c6c2543668831474c8e9bf62b rdf:first sg:person.01064502270.46
    171 rdf:rest rdf:nil
    172 Nec72ad457026468caab6874b4b12f704 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Acute Disease
    174 rdf:type schema:DefinedTerm
    175 Nedfde5b78b734cbba443acc68f152d70 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name Humans
    177 rdf:type schema:DefinedTerm
    178 Nf275fd34cbd5452cb087a66a03cbfd1b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    179 schema:name Antineoplastic Agents
    180 rdf:type schema:DefinedTerm
    181 Nf45d263c37ab41f6b61b6309b0facac4 rdf:first sg:person.0603732723.41
    182 rdf:rest N44cfce8d74b34b8597cc047d2a652b88
    183 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    184 schema:name Medical and Health Sciences
    185 rdf:type schema:DefinedTerm
    186 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    187 schema:name Cardiorespiratory Medicine and Haematology
    188 rdf:type schema:DefinedTerm
    189 sg:journal.1097065 schema:issn 0887-6924
    190 1476-5551
    191 schema:name Leukemia
    192 schema:publisher Springer Nature
    193 rdf:type schema:Periodical
    194 sg:person.01064502270.46 schema:affiliation grid-institutes:grid.462844.8
    195 schema:familyName Marie
    196 schema:givenName J-P
    197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01064502270.46
    198 rdf:type schema:Person
    199 sg:person.0603732723.41 schema:affiliation grid-institutes:grid.462844.8
    200 schema:familyName Simonin
    201 schema:givenName G
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0603732723.41
    203 rdf:type schema:Person
    204 sg:person.0717353373.00 schema:affiliation grid-institutes:None
    205 schema:familyName Zittoun
    206 schema:givenName R
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717353373.00
    208 rdf:type schema:Person
    209 sg:person.0752753564.08 schema:affiliation grid-institutes:grid.462844.8
    210 schema:familyName Legrand
    211 schema:givenName O
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0752753564.08
    213 rdf:type schema:Person
    214 sg:pub.10.1007/978-1-4615-3794-6_17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027880744
    215 https://doi.org/10.1007/978-1-4615-3794-6_17
    216 rdf:type schema:CreativeWork
    217 sg:pub.10.1038/nm0695-578 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031275541
    218 https://doi.org/10.1038/nm0695-578
    219 rdf:type schema:CreativeWork
    220 grid-institutes:None schema:alternateName Service d'matologie Clinique, Paris, France
    221 schema:name EA1529, Université Paris 6, Formation de Recherche Associée Claude Bernard sur le Traitement des Hémopathies Malignes, Paris, France
    222 Service d'matologie Clinique, Paris, France
    223 rdf:type schema:Organization
    224 grid-institutes:grid.462844.8 schema:alternateName EA1529, Université Paris 6, Formation de Recherche Associée Claude Bernard sur le Traitement des Hémopathies Malignes, Paris, France
    225 schema:name EA1529, Université Paris 6, Formation de Recherche Associée Claude Bernard sur le Traitement des Hémopathies Malignes, Paris, France
    226 Service d'matologie Biologique, Paris, France
    227 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...